Form 4: Solid Biosciences Director Ilan Ganot Reports Stock Transactions
SEC Form 4 Filing
Director Ilan Ganot of Solid Biosciences Inc. reports the acquisition and disposal of company stock and restricted stock units.
Summary
- Ilan Ganot, a director at Solid Biosciences Inc., reported several transactions involving the company's stock.
- On January 3, 2025, 2,994 restricted stock units vested and converted to common stock.
- Also on January 3, 2025, 2,994 shares were acquired indirectly through his wife.
- On January 6, 2025, 1,056 shares were sold at $4.31 per share to cover withholding taxes related to the vesting of restricted stock units.
- Following these transactions, Mr. Ganot directly owns 94,807 shares and indirectly owns 11,445 shares through his wife.
- Additionally, 19,394 shares are held in an irrevocable trust for which Mr. Ganot and his wife are trustees.
- Mr. Ganot also indirectly owns 5,988 restricted stock units through his wife.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions, with no indication of positive or negative sentiment. It is a routine filing.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company directors.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- The transactions reported are typical for directors who receive stock-based compensation and may need to sell shares to cover tax obligations.
- The sale of shares to cover withholding taxes is a common practice among executives and directors.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are unlikely to cause significant fluctuations.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 01/03/2025 | Restricted stock units vested and converted to common stock; indirect acquisition of shares. |
| 01/06/2025 | Sale of shares to cover withholding taxes. |
| 01/07/2025 | Date of signature for the Form 4 filing. |
Keywords
Solid Biosciences, stock transactions, insider trading, restricted stock units, Form 4, Ilan Ganot, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.